Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Open Access
- 1 December 1994
- journal article
- Published by Springer Nature in Nature
- Vol. 372 (6507) , 686-691
- https://doi.org/10.1038/372686a0
Abstract
Anandamide (N-arachidonoyl-ethanolamine) was recently identified as a brain arachidonate derivative that binds to and activates cannabinoid receptors, yet the mechanisms underlying formation, release and inactivation of this putative messenger molecule are still unclear. Here we report that anandamide is produced in and released from cultured brain neurons in a calcium ion-dependent manner when the neurons are stimulated with membrane-depolarizing agents. Anandamide formation occurs through phosphodiesterase-mediated cleavage of a novel phospholipid precursor, N-arachidonoyl-phosphatidylethanolamine. A similar mechanism also governs the formation of a family of anandamide congeners, whose possible roles in neuronal signalling remain unknown. Our results and those of others indicate therefore that multiple biochemical pathways may participate in anandamide formation in brain tissue. The life span of extracellular anandamide is limited by a rapid and selective process of cellular uptake, which is accompanied by hydrolytic degradation to ethanolamine and arachidonate. Our results thus strongly support the proposed role of anandamide as an endogenous neuronal messenger.Keywords
This publication has 19 references indexed in Scilit:
- Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes.Proceedings of the National Academy of Sciences, 1994
- The ATP- and CoA-independent synthesis of arachidonoylethanolamide. A novel mechanism underlying the synthesis of the endogenous ligand of the cannabinoid receptor.Published by Elsevier ,1994
- Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiationNature, 1994
- Cross‐tolerance between delta‐9‐tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212‐2 and anandamideBritish Journal of Pharmacology, 1993
- Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonistBiochemical Pharmacology, 1993
- Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction.Proceedings of the National Academy of Sciences, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Platelet-activating factor (PAF) receptor in rat brain: PAF mobilizes intracellular Ca2+ in hippocampal neuronsNeuron, 1992
- NGF gene expression in actively growing brain gliaJournal of Neuroscience, 1991
- Enzymatic formation of fatty acid amides of ethanolamine by rat liver microsomesBiochemical and Biophysical Research Communications, 1963